# Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy

> **NCT05034289** · NA · COMPLETED · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 81 (actual)

## Conditions studied

- Clinical Trials
- Immunotherapy

## Interventions

- **BEHAVIORAL:** PINPOINT Digital Educational Tool

## Key facts

- **NCT ID:** NCT05034289
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-12
- **Primary completion:** 2023-05-19
- **Final completion:** 2023-05-19
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05034289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05034289, "Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05034289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*